InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,181.21
(
-0.13%
)
US TECH 100
17,589.20
(
-0.13%
)
Dow Jones
38,898.29
(
0.04%
)
Brent Oil
82.50
(
-0.45%
)
Bitcoin
62,415.00
(
0.13%
)
Post# of 251750
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119592
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 221552

Monday, 10/22/2018 3:52:58 PM

Monday, October 22, 2018 3:52:58 PM

Post# of 251750

…NKTR has a collaboration with SNDX (where they test 214 in combo with entinostat…

Right, but no data from that collaboration are available yet (#msg-141180940); the phase-1/2 trial has not even started, as far as I know. So, today’s NKTR selloff and today’s SNDX selloff are not directly related.

‘dangerM’ also commented on Roche’s IL-2 program, which could be the main impetus for NKTR’s selloff.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up